The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 18,301–18,400 of 31,469
Kim, N., & Park, S. (2014) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.6685 · Cited by 15
NUCB2 gene polymorphism and its relationship with nesfatin-1 levels in polycystic ovary syndrome
Taşkın, M. İ., Eser, B., Adalı, E., Kara, H., Cuce, C., & Hişmioğulları, A. A. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1081682 · Cited by 14
Chien, C., Lin, C., Hu, C., et al. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0200 · Cited by 14
Roemmler, J., Gockel, A., Otto, B., Bidlingmaier, M., & Schopohl, J. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04146.x · Cited by 15
Body composition, pre‐diabetes and cardiovascular disease risk in early schizophrenia
Strassnig, M., Clarke, J., Mann, S. W., Remington, G. J., & Ganguli, R. (2015) · Early Intervention in Psychiatry · doi:10.1111/eip.12225 · Cited by 14
Kosola, S. K., Lampela, H., Gylling, H., Jalanko, H., Nissinen, M. J., Lauronen, J., Mäkisalo, H., Vaaralahti, K., Miettinen, T. A., Raivio, T., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04147.x · Cited by 15
Resistin and Postburn Insulin Dysfunction
Duffy, S. L., LaGrone, L., Herndon, D. N., et al. (2009) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e31815ebad4 · Cited by 14
Davidson, M. H., Rooney, M., Pollock, E., Drucker, J. L., & Choy, Y. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.06.001 · Cited by 14
Château‐Degat, M., Dannenbaum, D. A., Egeland, G. M., Nieboer, E., Laouan-Sidi, E. A., Abdous, B., & Dewailly, É. (2011) · Obesity · doi:10.1038/oby.2011.77 · Cited by 14
Haghighatdoost, F., Hosseinzadeh‐Attar, M. J., Akram, K., Eshraghian, M., & Esmaillzadeh, A. (2012) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2012.665044 · Cited by 14
Thomsen, K. L., Nielsen, S. S., Aagaard, N. K., et al. (2010) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365511003599537 · Cited by 14
Factors influencing blood pressure control in children and adolescents
Koulouridis, E., Georgalidis, K., Kostimpa, I., Kalantzi, M., Ntouto, P., Koulouridis, I., Mandyla, M., Krokida, A., & Boulgari, N. (2008) · International Urology and Nephrology · doi:10.1007/s11255-008-9340-0 · Cited by 13
Eilat-Adar, S., Xu, J., Goldbourt, U., Zephier, E. M., Howard, B. V., & Resnick, H. E. (2008) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2008.02.023 · Cited by 14
Boronat, M., Saavedra, P., Varillas, V. F., et al. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.07.007 · Cited by 14
Cornford, A. S., Barkan, A. L., Hinko, A., & Horowitz, J. F. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00320.2012 · Cited by 14
Vonbank, A., Saely, C. H., Rein, P., Beer, S., Breuss, J., Boehnel, C., & Drexel, H. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.02.008 · Cited by 14
Plasma adiponectin is associated with less atherogenic lipoprotein phenotype
Shin, M., & Kim, O. Y. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.01.014 · Cited by 14
Güven, S., Karahan, S. C., Bayram, C., Uçar, U., & Özeren, M. (2009) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2009.05.012 · Cited by 14
Kondo, T., Sasaki, K., Adachi, H., Nakayama, Y., Hatemura, M., Matsuyama, R., Tsuruzoe, K., Furukawa, N., Motoshima, H., Morino, S., et al. (2009) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2009.09.007 · Cited by 14
Sai, E., Shimada, K., Yokoyama, T., Sato, S., Nishizaki, Y., Miyazaki, T., Hiki, M., Tamura, Y., Aoki, S., Watada, H., et al. (2015) · Internal Medicine · doi:10.2169/internalmedicine.54.3024 · Cited by 14
Assar, M. E., Angulo, J., Santos-Ruiz, M., Moreno, P., Novials, A., Villanueva‐Peñacarrillo, M. L., & Rodríguez‐Mañas, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120479 · Cited by 14
IGF-1 gene polymorphism in obese patients with insulin resistance
Yaylalı, G. F., Akın, F., Turgut, S., & Kurşunluoğlu, R. (2009) · Molecular Biology Reports · doi:10.1007/s11033-009-9729-6 · Cited by 14
Sirikwanpong, S., Dahlan, W., Ngamukote, S., et al. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.10-21 · Cited by 14
Valle, E. D., Stranges, S., Trevisan, M., Strazzullo, P., Siani, A., & Farinaro, E. (2004) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(04)80034-6 · Cited by 14
Genç, H., Doğru, T., Tapan, S., Taşçı, İ., Bozoğlu, E., Gök, M., Aslan, F., Çelebi, G., Erdem, G., Avcu, F., et al. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.10.022 · Cited by 14
Lecke, S. B., Morsch, D. M., & Spritzer, P. M. (2011) · Steroids · doi:10.1016/j.steroids.2011.07.008 · Cited by 14
Camhi, S. M., Katzmarzyk, P. T., Broyles, S. T., Church, T. S., Hankinson, A. L., Carnethon, M. R., Sternfeld, B., & Lewis, C. E. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0120 · Cited by 13
Orotic Acid Induces Hypertension Associated with Impaired Endothelial Nitric Oxide Synthesis
Choi, Y., Yoon, Y., Lee, K.-Y., Kang, Y.-P., Lim, D. K., Kwon, S. W., Kang, K.-W., Lee, S.-M., & Lee, B. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv003 · Cited by 14
Síndrome metabólica em adolescentes com sobrepeso e obesidade
Souza, M. S. F. E., Leme, R. B., Franco, R. R., Romaldini, C. C., Tumas, R., Cardoso, A. L., & Damiani, D. (2007) · Revista Paulista de Pediatria · doi:10.1590/s0103-05822007000300004 · Cited by 14
Oral contraceptive use and abnormal glucose regulation in Swedish middle aged women
Deleskog, A., Hilding, A., & Östenson, C. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.02.014 · Cited by 14
Christen, A., Efstathiadou, Z. A., Laspa, E., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2267 · Cited by 14
Lee, K., Song, Y., & Sung, J. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0098 · Cited by 14
Duvillard, L., Florentin, E., Pont, F., Petit, J., Baillot-Rudoni, S., Penfornis, A., & Vergès, B. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2946 · Cited by 15
González-Guardia, L., Yubero‐Serrano, E. M., Rangel-Zúñiga, O. A., Marı́n, C., Camargo, A., Pérez‐Martínez, P., Delgado‐Lista, J., Gómez-Delgado, F., García‐Ríos, A., Tinahones, F. J., et al. (2014) · AGE · doi:10.1007/s11357-014-9681-9 · Cited by 14
Tu, Y., Yu, H., Zhang, P., Di, J., Han, X., Wu, S.-H., Bao, Y., & Jia, W. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12200 · Cited by 14
Collison, K. S., Zaidi, M. Z., Saleh, S. M., Makhoul, N. J., Inglis, A. L., Burrows, J., Araujo, J. A., & Al-Mohanna, F. A. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0261-7 · Cited by 14
Mahfouz, R. A., Gomma, A., Goda, M., & Safwat, M. (2014) · Echocardiography · doi:10.1111/echo.12824 · Cited by 14
Pathophysiologic heterogeneity in the development of type 2 diabetes mellitus in Korean subjects
Kang, H. W., Kim, D. J., Lee, M., Kim, K., & Lee, M. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.12.011 · Cited by 14
Weng, S., Shu, K., Tang, Y.-J., Sheu, W. H., Tarng, D., Wu, M.-J., Chen, Y., & Chuang, Y. (2012) · Internal Medicine · doi:10.2169/internalmedicine.51.5975 · Cited by 14
Factors responsible for elevation of 1-h postchallenge plasma glucose levels in Japanese men
Harada, N., Fukushima, M., Toyoda, K., Mitsui, R., Izuka, T., Taniguchi, A., Nakai, Y., Yamada, Y., Seino, Y., & Inagaki, N. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.04.011 · Cited by 15
Gil‐Campos, M., Ramírez-Tortosa, M. C., Aguilera, C. M., Cañete, R., & Gil, Á. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.07.003 · Cited by 15
Ameliorative Effect of Allopurinol on Vascular Complications of Insulin Resistance
El‐Bassossy, H. M., Elberry, A. A., Azhar, A. S., Ghareib, S. A., & Alahdal, A. M. (2015) · Journal of Diabetes Research · doi:10.1155/2015/178540 · Cited by 14
Anormalidades metabólicas em mulheres com síndrome dos ovários policísticos: obesas e não obesas
Romano, L. G. M., Bedoschi, G., de Melo, A. S., de Albuquerque, F. O., Silva, A. C. J. D. S. R. E., Ferriani, R. A., & Navarro, P. A. (2011) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032011000600008 · Cited by 14
Saucedo, R., Basurto, L., Zárate, A., Martínez, C., Hernández, M., & Galván, R. E. (2007) · Gynecologic and Obstetric Investigation · doi:10.1159/000099148 · Cited by 14
Arteaga, A., Bustos, P., Soto, R. N., Velasco, N., & Amigo, H. (2010) · Revista médica de Chile · doi:10.4067/s0034-98872010001100001 · Cited by 14
Li, S., Yang, B., Gong, H., Tan, H., Zhong, M., Zhang, Y., & Zhang, W. (2009) · Hypertension Research · doi:10.1038/hr.2009.105 · Cited by 14
Assessment of serum IGF-1 and adipokines related to metabolic dysfunction in HIV-infected adults
Parfieniuk‐Kowerda, A., Czaban, S. L., Grzeszczuk, A., et al. (2013) · Cytokine · doi:10.1016/j.cyto.2013.07.018 · Cited by 14
Leti, T., Guinot, M., Favre‐Juvin, A., & Bricout, V. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.02.007 · Cited by 17
Menick, F. J. (2001) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-200108000-00034 · Cited by 14
Effect of Omega-3 Fatty Acids on Erythrocyte Membrane in Diabetic Rats
Hussein, J., Mostafa, E. F. A., El-Wassef, M., El-Khayat, Z., Badawy, E. A., & Medhat, D. (2011) · Macedonian Journal of Medical Sciences · doi:10.3889/mjms.1857-5773.2011.0180 · Cited by 14
Seow, K., Tsai, Y.-L., Juan, C., Lin, Y., Hwang, J., & Ho, L. (2009) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2009.05.003 · Cited by 14
Aziz, M. Z., Naver, K. V., Wissing, M. L., Mikkelsen, A., Nilas, L., & Skouby, S. O. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.613966 · Cited by 14
The Association of Hypertension with Obesity and Metabolic Abnormalities among Chinese Children
Xu, H., Hu, X., Zhang, Q., Du, S., Fang, H., Li, Y., Ma, J., Li, T., Du, L., Guo, H., et al. (2011) · International Journal of Hypertension · doi:10.4061/2011/987159 · Cited by 14
Lawrence, N. J., Κousta, E., Penny, A., Millauer, B. A., Robinson, S., Johnston, D. G., & McCarthy, M. I. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01473.x · Cited by 14
Olijhoek, J. K., Koerselman, J., de Jaegere, P. P. T., Verhaar, M. C., Grobbee, D. E., van der Graaf, Y., Visseren, F. L. J., & for the SMART Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.3.683 · Cited by 14
Gelwane, G., Trang, H., Carel, J., Dauger, S., & Léger, J. (2013) · Jornal de Pediatria · doi:10.1016/j.jpeds.2012.06.036 · Cited by 10
Jung, C., Rhee, E., Kim, K.-J., Kim, B., Park, S. E., Chang, Y., Ryu, S., Park, C., Mok, J., Oh, K.-W., et al. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.11.011 · Cited by 14
Almeda‐Valdés, P., Ramos, D. C., Mehta, R., Muñóz-Hernández, L. L., Cruz‐Bautista, I., Pérez-Méndez, O. A., Tusié-Luna, M. T., Gomez-Perez, F. J., Pajukanta, P., Matikainen, N., et al. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-90 · Cited by 14
Maternal influence of prolyl endopeptidase on fat mass of adult progeny
Warden, C. H., Fisler, J. S., Espinal, G., et al. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.129 · Cited by 14
Samaan, M. C., Anand, S. S., Sharma, A. M., Samjoo, I. A., & Tarnopolsky, M. A. (2015) · Scientific Reports · doi:10.1038/srep09154 · Cited by 15
Kawamoto, R., Tabara, Y., Kohara, K., Miki, T., Kusunoki, T., Katho, T., & Ohtsuka, N. (2011) · Endocrine Research · doi:10.3109/07435800.2010.534754 · Cited by 14
García–Álvarez, M., Guzmán, M. G., Berenguer, J., et al. (2011) · AIDS · doi:10.1097/qad.0b013e328349820f · Cited by 14
Serum Interleukin 17 in Type 2 Diabetes Mellitus
Zareian, P., & Mirzaii‐Dizgah, I. (2014) · Journal of Archives in Military Medicine · doi:10.5812/jamm.24689 · Cited by 14
Kim, H. J., Ryu, J., Ahn, S. Y., Kim, S., Lim, S. K., Na, K. Y., Kim, K. W., Jang, H. C., Chae, D., & Chin, H. J. (2013) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.231.271 · Cited by 14
Insulin resistance in young adults born small for gestational age (SGA)
Putzker, S., Pozza, S. B., Kugler, K., et al. (2013) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2013-0292 · Cited by 14
Harmuth, S., Wewalka, M., Holst, J. J., Nemecek, R., Thalhammer, S., Schmid, R. W., Sahora, K., Gnant, M., & Miholic, J. (2013) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-013-2283-5 · Cited by 15
Aydoğdu, A., Taşçı, İ., Küçükerdönmez, Ö., Tapan, S., Aydogdu, S., Aydoğan, Ü., Sönmez, A., Yazıcı, M., & Azal, Ö. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.708802 · Cited by 14
Blum, J., Aeschbacher, S., Schoen, T., Bossard, M., Pumpol, K., Brasier, N., Risch, M., Risch, L., & Conen, D. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0659-y · Cited by 14
Hutchinson, M. S., Joakimsen, R. M., Njølstad, I., Schirmer, H., Figenschau, Y., Svartberg, J. B., & Jorde, R. (2013) · International Journal of Endocrinology · doi:10.1155/2013/613475 · Cited by 17
Ebenibo, S., Edeoga, C., Wan, J. Y., & Dagogo-Jack, S. E. (2014) · Metabolism · doi:10.1016/j.metabol.2014.03.002 · Cited by 15
Influence of daily alcohol consumption on serum adiponectin levels in men
Makita, S., Abiko, A., Nagai, M., Yonezawa, S., Koshiyama, M., Ohta, M., & Nakamura, M. (2012) · Metabolism · doi:10.1016/j.metabol.2012.09.003 · Cited by 14
Tsunekawa, K., Yanagawa, Y., Aoki, T., Morimura, T., Araki, O., Ogiwara, T., Kawai, Y., Mitani, Y., Lezhava, A., Yanagawa, M., et al. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0148 · Cited by 14
Seven, E., Husemoen, L. L. N., Ibsen, H., Friedrich, N., Nauck, M. A., Wachtell, K., Linneberg, A. R., & Jeppesen, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117864 · Cited by 14
Effects of Hormone Replacement Therapy on Insulin Resistance and Platelet Function Tests
Saraç, F., Saydam, G., Şahin, F., Öztekin, K., Saygılı, F., Tüzün, M., & Yılmaz, C. (2008) · Medical Principles and Practice · doi:10.1159/000163045 · Cited by 14
Montastier, É., Dejean, S., Gall, C. L., Saris, W. H. M., Langin, D., & Viguerie, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098707 · Cited by 14
Gradillas-García, A., Álvarez, J., Rubio, J. A., & de Abajo, F. J. (2015) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2014.12.008 · Cited by 14
Metalloproteinases in Diabetics and Nondiabetics during Acute Coronary Syndromes and after 3 Months
Derosa, G., Cicero, A. F. G., Scalise, F., et al. (2007) · Endothelium · doi:10.1080/10623320701606475 · Cited by 14
Gray, D. L., O’Brien, K. D., D’Alessio, D. A., Brehm, B. J., & Deeg, M. A. (2008) · Metabolism · doi:10.1016/j.metabol.2007.11.007 · Cited by 14
Henry, R. R., Buse, J. B., Wu, H., Durrwell, L., Mingrino, R., Jaekel, K., Azzouzi, B. E., Andjelković, M., & Herz, M. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12455 · Cited by 14
Aerobic fitness and cognitive function in midlife: an association mediated by plasma insulin
Tarumi, T., Gonzales, M. M., Fallow, B. A., et al. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-013-9431-1 · Cited by 14
Premature Aging of Cardiovascular/Platelet Function in Polycystic Ovarian Syndrome
Chan, W. P. A., Ngo, D. T. M., Sverdlov, A. L., Rajendran, S., Stafford, I., Heresztyn, T., Chirkov, Y. Y., & Horowitz, J. D. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.12.015 · Cited by 14
Anan, F., Masaki, T., Umeno, Y., Iwao, T., Yonemochi, H., Eshima, N., Saikawa, T., & Yoshimatsu, H. (2008) · Metabolism · doi:10.1016/j.metabol.2007.09.013 · Cited by 14
II Consenso de la Sociedad Chilena de Endocrinología y Diabetes sobre resistencia a la insulina
Felipe Pollak, C., Araya, V., Lanas, A., SAPUNAR, J., Arrese, M. A., Aylwin, C. G., Bezanilla, C. G., Carrasco, E., Fernando Carrasco, N., Ethel Codner, D., et al. (2015) · Revista médica de Chile · doi:10.4067/s0034-98872015000500012 · Cited by 17
Lee, G. A., Rao, M. N., & Grünfeld, C. (2006) · American Journal of Infectious Diseases · doi:10.3844/ajidsp.2006.159.166 · Cited by 14
Arıkan, D. C., Özkaya, M., Adalı, E., Kılınç, M., Coşkun, A., Özer, A., & Bilge, F. (2010) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2010.487138 · Cited by 14
Laurito, M., & Parise, E. R. (2013) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2013.02.009 · Cited by 14
Endocrine Pancreatic Dysfunction in HIV‐Infected Children: Association with Growth Alterations
Rondanelli, M., Caselli, D., Trotti, R., Solerte, S. B., Maghnie, M., Maccabruni, A., Minoli, L., & Ferrari, E. (2004) · The Journal of Infectious Diseases · doi:10.1086/422255 · Cited by 14
de Luis, D. A., Aller, R., Conde, R., et al. (2013) · PubMed · doi:10.3305/nh.2012.27.4.5851 · Cited by 14
Atabek, M. E., Kurtoğlu, S., & Keskın, M. (2005) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2005.2709 · Cited by 14
Serum Adiponectin and Cardiometabolic Risk in Patients with Acute Coronary Syndromes
Oliveira, G. B. D. F., França, J. Í. D., & Piegas, L. S. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20130186 · Cited by 14
Sex differences in lipid profiles in relation to the progression of glucose abnormalities
Schianca, G. P. C., Fra, G. P., Colli, E., Bigliocca, M., Mella, R., Scaglia, E., & Bartoli, E. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00160.x · Cited by 14
Kim, H. M., Lim, J. S., Lee, B., Kang, E. S., Lee, H. C., & Soo, B. (2015) · Endocrinology and Metabolism · doi:10.3803/enm.2015.30.1.84 · Cited by 14
Effect of weight loss on maximal fat oxidation rate in obese men
Tsujimoto, T., Sasai, H., Miyashita, M., Eto, M., So, R., Ohkubo, H., & Tanaka, K. (2011) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2011.06.003 · Cited by 14
Sosin, M. D., Patel, J. V., Bhatia, G. S., Hughes, E. A., Davis, R., & Lip, G. Y. H. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.04.112 · Cited by 14
Gonçalves-Neto, L. M., Ferreira, F. B. D., de Souza, L. F., dos Santos, C., Boschero, A. C., Facundo, V. A., Santos, A. R. S., Nunes, E. A., & Rafacho, A. (2014) · PubMed · Cited by 14
Atanasovska, E., Tasic, V. B., Slaninka-Miceska, M., et al. (2014) · PubMed · Cited by 14
O’Sullivan, T. A., Bremner, A., Mori, T. A., Beilin, L. J., Wilson, C., Hafekost, K., Ambrosini, G. L., Huang, R. C., & Oddy, W. H. (2016) · Nutrients · doi:10.3390/nu8010022 · Cited by 14
Are obesity and metabolic syndrome associated with plasma adropin levels in children?
Kocaoğlu, Ç., Büyükinan, M., Erdem, S. S., et al. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0117 · Cited by 14
Ali, S. A. E.-M., Nassif, W. M. H., & Abdelaziz, D. H. (2016) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.12.003 · Cited by 14
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
